Expanded Access Protocol of ELI-002-102 in Subjects With KRAS/NRAS Mutated Pancreatic Ductal Adenocarcinoma
Clinical trial NCT07083479 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT07083479
- Sponsor
- Elicio Therapeutics
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.